4//SEC Filing
Conway Kevin John 4
Accession 0001415889-25-019923
CIK 0001733294other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:10 PM ET
Size
8.6 KB
Accession
0001415889-25-019923
Insider Transaction Report
Form 4
Conway Kevin John
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-07-15−587→ 3,520 total→ Common Stock (587 underlying) - Tax Payment
Common Stock
2025-07-15$0.43/sh−173$74→ 18,273 total - Exercise/Conversion
Common Stock
2025-07-15+587→ 18,446 total
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
- [F2]The grant of 9,390 restricted stock units was made on January 20, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
Related Parties
1- filerCIK 0002051408
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 4:10 PM ET
- Size
- 8.6 KB